Plant-Derived Antimicrobials as Next-Generation Solutions to Multidrug Resistance

Year : 2026 | Volume : 17 | 02 | Page :
    By

    Rohit kumar,

  • Shraddha Pareek,

  • Tanya Sharma,

  • Kamalesh Mistry,

  1. Research Scholar, Faculty of Pharmaceutical Science, Mewar University, Gangrar, Chittorgarh, Rajasthan, India
  2. Assistant Professor, Department of Pharmacy, Faculty of Pharmaceutical Science, Mewar University, Gangrar, Chittorgarh, Rajasthan, India
  3. Assistant Professor, Department of Pharmacy, Faculty of Pharmaceutical Science, Mewar University, Gangrar, Chittorgarh, Rajasthan, India
  4. Associate Professor, Department of Pharmacy, Faculty of Pharmaceutical Science, Mewar University, Gangrar, Chittorgarh, Rajasthan, India

Abstract

The steady rise of multidrug-resistant (MDR) pathogens is reshaping how clinicians, researchers, and policymakers think about infection control. When bacteria acquire the ability to survive exposure to three or more antibiotic classes at once—whether through efflux pumps, enzyme-mediated drug destruction, target modifications, or reduced membrane permeability—treatment options narrow dramatically, hospital stays lengthen, and mortality climbs. Conventional pharmaceutical pipelines have struggled to keep pace with this biological arms race, pushing the scientific community to look beyond synthetic chemistry for novel solutions. Plants have evolved rich arsenals of bioactive secondary metabolites over hundreds of millions of years of co-evolution with microbial pathogens. Alkaloids such as berberine, flavonoids such as epigallocatechin gallate, terpenoids such as thymol and carvacrol, tannins, saponins, and quinone derivatives each offer mechanistic approaches that differ fundamentally from those of conventional antibiotics—disrupting microbial membranes, blocking efflux machinery, interfering with quorum-sensing communication, and inhibiting resistance enzymes. When intelligently combined with existing drugs, many of these compounds restore sensitivity in isolates that had previously been classified as untreatable.

Keywords: Plant-derived antimicrobials; multidrug resistance; phytochemicals; Tecomella undulata; ESKAPE pathogens; synergistic therapy; nanoformulation; antibiotic resistance

How to cite this article:
Rohit kumar, Shraddha Pareek, Tanya Sharma, Kamalesh Mistry. Plant-Derived Antimicrobials as Next-Generation Solutions to Multidrug Resistance. Research and Reviews: A Journal of Pharmaceutical Science. 2026; 17(02):-.
How to cite this URL:
Rohit kumar, Shraddha Pareek, Tanya Sharma, Kamalesh Mistry. Plant-Derived Antimicrobials as Next-Generation Solutions to Multidrug Resistance. Research and Reviews: A Journal of Pharmaceutical Science. 2026; 17(02):-. Available from: https://journals.stmjournals.com/rrjops/article=2026/view=240528


References

1. World Health Organization. (2022). Global antimicrobial resistance and use surveillance system (GLASS) report: 2022. WHO Press.
2. Cowan, M. M. (1999). Plant products as antimicrobial agents. Clinical Microbiology Reviews, 12(4), 564–582. https://doi.org/10.1128/CMR.12.4.564
3. Khameneh, B., Iranshahy, M., Soheili, V., & Bazzaz, B. S. F. (2019). Review on plant antimicrobials: A mechanistic viewpoint. Antimicrobial Resistance and Infection Control, 8, Article 118. https://doi.org/10.1186/s13756-019-0559-6
4. O’Neill, J. (2016). Tackling drug-resistant infections globally: Final report and recommendations. Review on Antimicrobial Resistance. HM Government.
5. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., Paterson, D. L., Rice, L. B., Stelling, J., Struelens, M. J., Vatopoulos, A., Weber, J. T., & Monnet, D. L. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection, 18(3), 268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x
6. Piddock, L. J. V. (2006). Multidrug-resistance efflux pumps—not just for resistance. Nature Reviews Microbiology, 4(8), 629–636. https://doi.org/10.1038/nrmicro1464
7. Fabricant, D. S., & Farnsworth, N. R. (2001). The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives, 109(Suppl. 1), 69–75. https://doi.org/10.1289/ehp.01109s169
8. Hemaiswarya, S., Kruthiventi, A. K., & Doble, M. (2008). Synergism between natural products and antibiotics against infectious diseases. Phytomedicine, 15(8), 639–652. https://doi.org/10.1016/j.phymed.2008.06.008
9. Stavri, M., Piddock, L. J. V., & Gibbons, S. (2007). Bacterial efflux pump inhibitors from natural sources. Journal of Antimicrobial Chemotherapy, 59(6), 1247–1260. https://doi.org/10.1093/jac/dkl460
10. Rice, L. B. (2008). Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. Journal of Infectious Diseases, 197(8), 1079–1081. https://doi.org/10.1086/533452
11. Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014). Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data. The Lancet Infectious Diseases, 14(8), 742–750. https://doi.org/10.1016/S1473-3099(14)70780-7
12. Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., Greko, C., So, A. D., Bigdeli, M., Tomson, G., Woodhouse, W., Ombaka, E., Peralta, A. Q., Qamar, F. N., Mir, F., … Cars, O. (2013). Antibiotic resistance—the need for global solutions. The Lancet Infectious Diseases, 13(12), 1057–1098. https://doi.org/10.1016/S1473-3099(13)70318-9
13. Cushnie, T. P. T., & Lamb, A. J. (2005). Antimicrobial activity of flavonoids. International Journal of Antimicrobial Agents, 26(5), 343–356. https://doi.org/10.1016/j.ijantimicag.2005.09.002
14. Daglia, M. (2012). Polyphenols as antimicrobial agents. Current Opinion in Biotechnology, 23(2), 174–181. https://doi.org/10.1016/j.copbio.2011.08.007
15. Sudano Roccaro, A., Blanco, A. R., Giuliano, F., Rusciano, D., & Enea, V. (2004). Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrobial Agents and Chemotherapy, 48(6), 1968–1973. https://doi.org/10.1128/AAC.48.6.1968-1973.2004
16. Gibbons, S. (2004). Anti-staphylococcal plant natural products. Natural Product Reports, 21(2), 263–277. https://doi.org/10.1039/b212695h
17. Burt, S. (2004). Essential oils: Their antibacterial properties and potential applications in foods—a review. International Journal of Food Microbiology, 94(3), 223–253. https://doi.org/10.1016/j.ijfoodmicro.2004.03.022
18. Carson, C. F., Hammer, K. A., & Riley, T. V. (2006). Melaleuca alternifolia (tea tree) oil: A review of antimicrobial and other medicinal properties. Clinical Microbiology Reviews, 19(1), 50–62. https://doi.org/10.1128/CMR.19.1.50-62.2006
19. O’Gara, E. A., Hill, D. J., & Maslin, D. J. (2000). Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Applied and Environmental Microbiology, 66(5), 2269–2273. https://doi.org/10.1128/AEM.66.5.2269-2273.2000
20. Moghadamtousi, S. Z., Kadir, H. A., Hassandarvish, P., Tajik, H., Abubakar, S., & Zandi, K. (2014). A review on antibacterial, antiviral, and antifungal activity of curcumin. BioMed Research International, 2014, Article 186864. https://doi.org/10.1155/2014/186864
21. Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007). Bioavailability of curcumin: Problems and promises. Molecular Pharmaceutics, 4(6), 807–818. https://doi.org/10.1021/mp700113r
22. Borges, A., Saavedra, M. J., & Simões, M. (2012). The activity of ferulic and gallic acids in biofilm prevention and control of pathogenic bacteria. Biofouling, 28(7), 755–767. https://doi.org/10.1080/08927014.2012.706751
23. Simoes, M., Simoes, L. C., & Vieira, M. J. (2010). A review of current and emergent biofilm control strategies. LWT—Food Science and Technology, 43(4), 573–583. https://doi.org/10.1016/j.lwt.2009.12.008
24. Dhir, R., & Shekhawat, G. S. (2012). Critical review on Tecomella undulata: A medicinally potent endangered plant species of Indian Thar Desert. International Journal of Current Research, 6, 36–44.
25. Vats, S., Bhatt, D. L., Sharma, A., & Mathur, G. (2025). Ethnomedicinal, phytochemical, pharmacological, and conservation studies of an endangered plant: The desert teak (Tecomella undulata (Sm.) Seem.). Frontiers in Pharmacology, 16, Article 1665446. https://doi.org/10.3389/fphar.2025.1665446
26. Jain, N., Jain, R., Jain, A., Jain, D. K., & Chandel, H. S. (2012). Traditional uses, phytochemistry and pharmacology of Tecomella undulata—a review. Asian Pacific Journal of Tropical Biomedicine, 2(2), S479–S485. https://doi.org/10.1016/S2221-1691(12)60521-8
27. Khosravi, H., Solouki, M., & Ganjali, S. (2020). Investigating antibacterial properties of Tecomella undulata and Momordica charantia plant extracts on some pathogenic bacteria. Gene, Cell and Tissue, 7(1), Article e94960. https://doi.org/10.5812/gct.94960
28. Bhardwaj, R. (2018). GC-MS analysis and antimicrobial activity of alkaloids of Tecomella undulata. Journal of Medicinal Plants Studies, 6(6), 68–72.
29. Mathur, S., Sharma, P., & Choudhary, M. (2024). Quorum quenching activity of endophytic Bacillus sp. EBS9 from Tecomella undulata and its biocontrol applications. Biological Control, 190, Article 105441. https://doi.org/10.1016/j.biocontrol.2024.105441
30. Yap, P. S. X., Yiap, B. C., Ping, H. C., & Lim, S. H. E. (2014). Essential oils, a new horizon in combating bacterial antibiotic resistance. Open Microbiology Journal, 8, 6–14. https://doi.org/10.2174/1874285801408010006

Ahead of Print Subscription Review Article
Volume 17
02
Received 30/03/2026
Accepted 19/04/2026
Published 22/04/2026
Publication Time 23 Days
1

Login


My IP

PlumX Metrics